Mingyan Xu

机构：Xiamen University, Chinese Academy of Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Shenzhen Bioeasy Biotechnology (China), Fudan University Shanghai Cancer Center, Shanghai Institute of Materia Medica, Zhongshan Hospital of Xiamen University, Stomatology Hospital, University of Chinese Academy of Sciences, Xiamen Medical College, National Cheng Kung University · ORCID：0000-0002-0082-403X

发表论文 76 篇 · 总被引 1127 次 · h-index 17

代表论文

• Unleashing the power of urine‑based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review) (2025 · International Journal of Oncology · 被引 23)
• Decoding the mechanisms behind second primary cancers (2025 · Journal of Translational Medicine · 被引 20)
• Bridging chemistry and artificial intelligence by a reaction description language (2025 · Nature Machine Intelligence · 被引 11)
• Efficient sequencing data compression and FPGA acceleration based on a two-step framework (2023 · Frontiers in Genetics · 被引 11)
• A special electrostatic self-assembly structure of colloidal silica: Improving Chemical Mechanical Polishing performance (2024 · Materials Science in Semiconductor Processing · 被引 10)
• Safety, Efficacy, and Biomarker Analysis of Deulorlatinib (TGRX-326) in Anaplastic Lymphoma Kinase-Positive NSCLC: A Multicenter, Open-Label, Phase 1/1b Trial (2024 · Journal of Thoracic Oncology · 被引 7)